Stifel Reiterates Buy on DocGo, Maintains $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst David Grossman has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a $12 price target.
July 31, 2023 | 3:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst David Grossman has reiterated a 'Buy' rating on DocGo and maintained a $12 price target.
The reiteration of a 'Buy' rating by a Stifel analyst and the maintenance of a $12 price target indicates a positive outlook for DocGo. This could potentially lead to an increase in investor confidence and a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100